Competent Cells Market Research Report

Competent Cells Market by Type (Chemically Competent Cells, Electrocompetent Cells ) by Application /End User(Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded DNA Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)) by Competence (Natural Competence, Artificial Competence ) Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast

Number of pages: 168 | Report Code: PSMR- PSMR-00081 | Report Format : PDF

Report Coverage

Parameters Details

Base Year


Historical Data


Forecast Data


Base Year Value (2021)

USD 1344.16 million

Forecast Value (2029)

USD 2777.89 million

CAGR (2022 to 2029)

8.4 %

Regional Scope

North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW

Competent cells incorporate foreign DNA through altered cell walls to pass DNA more easily. Calcium chloride and Heat shock treatment are used to make cell “competent”. Electroporation is a process that includes brief exposure of cells to an electric field in order to pass DNA through it. Cells undergoing very rapid growth can be made competent easily than cells in other development phase. Bacterial culture has varies growth rate, in initial hours called lag phase with small number of dividing cells growth rate is low. In rapid growth phase also called Log phase under proper temperature cells can become competent easily.  

Competent Cells Market: Competence Type

Competence is distinguished based on the environment used to perform on bacterial cell transformation .Basically Competence type are:

Natural Competence

Cells are able to receive DNA from their environment by :

  • Conjugation
  • transformation
  • transduction

In transformation the DNA is directly pass into the cell. In order to receive transforming DNA recipient cells should be in a specialized physiological state called log phase or competent state.  

Artificial Competence

Artificial competence includes setting specific artificial conditions in which cells are made permeable to DNA in laboratory. It is relatively easy competence procedure and can be used in the genetic engineering of bacteria. Artificial competence is low efficiency process as cells are forces to adopt foreign DNA.

Competent Cells Market: Growth Outlook

Technological advancement and increasing need of genomic and protein expressed products are prime factors contributing to growth of Competent Cells Market.  

Competent Cells Market: Product Type

  • Chemically Competent Cells
  • Electrocompetent Cells

Competent Cells Market : Application

  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid creation
  • Cre-lox recombination (PIR1/PIR2)

Global Competent Cells Market: Competitive Analysis

Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Global Competent Cells Market:

  • Merck KGaA
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Takara Bio
  • Promega Corporation
  • Beijing TransGen Biotech
  • GeneScript Corporation
  • Yeastern Biotech
  • New England Biolabs
  • OriGene Technologies
  • Lucigen
  • Zymo Research
  • Bio-Rad Laboratories
  • Bioline
  • Delphi Genetics
  • IBA GmBH
  • Cell Applications
  • BioDynamics Laboratory
  • Scarab Genomics
  • GCC Biotech
  • SMOBIO Technology
  • Edge BioSystems

Geographical analysis of Competent Cells Market:

  • North America
    • U.S.A
    • Canada
  • Europe
    • France
    • Germany
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South East Asia
  • Latin America
    • Brazil
  • Middle East and Africa

Competent Cells Market Report delivers comprehensive analysis of :

  • Market Forecast for 2020-28
  • Market growth drivers
  • Challenges and Opportunities
  • Emerging and Current market trends
  • Market player Capacity, Production, Revenue (Value)
  • Supply (Production), Consumption, Export, Import analysis
  • End user/application Analysis

Frequently Asked Questions (FAQ)

Competent Cells Market was valued at around USD 1344.16 million in 2020 & estimated to reach USD 2777.89 by 2028.

Competent Cells Market is likely to grow at compounded annual growth rate (CAGR) of 8.4% between 2021 to 2028.

segment dominated the global market in terms of revenue generation. region is likely to show the highest growth rate between 2021 to 2028.

Some of the top companies included in the research report are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen.

Technological advancement and increasing need of genomic and protein expressed products are prime factors contributing to growth of Competent Cells Market.

Yes, the report includes COVID 19 impact on the market.

  Download Sample

Please fill below details:


    Select Licence Type

      Single User -          $2550

      Corporate User -   $3550

    Competent Cells Market Covid 19 Impact Analysis
    Why Profshare?

      High Data Accuracy

    Precise research methodology, numerous analysis models & up to date data resources to achive most accurate market values.

     Customization as Needed

    We can tailored the report as per your requirments & budget, Most of our clients prefer custom reports.

      Budget Friendly Solution

    We have quality market data for all types of budget & so now get best out of your market research budget.

      Quality Support

    Be assured of receving satisfactory analyst support to understand research report in-detail.